Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration
US11266658B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2018 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Mar 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6951
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.